Shenzhen Neptunus Bioengineering Co Ltd Total Liabilities
Shenzhen Neptunus Bioengineering Co Ltd total liabilities. Based on the latest financial reports, Shenzhen Neptunus Bioengineering Co Ltd (000078) has total liabilities worth CN¥23.58 Billion CNY (≈ $3.45 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 000078 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shenzhen Neptunus Bioengineering Co Ltd (1995–2025)
Total liabilities of Shenzhen Neptunus Bioengineering Co Ltd from 1995 to 2025. This chart illustrates how Shenzhen Neptunus Bioengineering Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Shenzhen Neptunus Bioengineering Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Shenzhen Neptunus Bioengineering Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shenzhen Neptunus Bioengineering Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC
PA:CCN
|
France | €20.28 Billion |
|
Irish Residential Properties
IR:IRES
|
Ireland | €589.47 Million |
|
First Foundation Inc.
NYSE:FFWM
|
USA | $10.99 Billion |
|
Keystone Realtors Limited
NSE:RUSTOMJEE
|
India | Rs38.28 Billion |
|
Wolong Real Estate Group Co Ltd
SHG:600173
|
China | CN¥4.13 Billion |
|
Mastek Limited
NSE:MASTEK
|
India | Rs13.17 Billion |
|
Shandong Haihua Co Ltd
SHE:000822
|
China | CN¥5.24 Billion |
|
Shanghai Zhenhua Heavy Industries Co Ltd B
SHG:900947
|
China | $65.29 Billion |
Liability Composition Analysis (1995–2025)
This chart breaks down Shenzhen Neptunus Bioengineering Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Shenzhen Neptunus Bioengineering Co Ltd.
Liquidity & Leverage Metrics
Shenzhen Neptunus Bioengineering Co Ltd Total Liabilities Ratios Explained
Shenzhen Neptunus Bioengineering Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 18.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.92 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shenzhen Neptunus Bioengineering Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shenzhen Neptunus Bioengineering Co Ltd (1995–2025)
The table below shows the annual total liabilities of Shenzhen Neptunus Bioengineering Co Ltd from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥24.16 Billion ≈ $3.53 Billion |
-6.93% |
| 2024-12-31 | CN¥25.95 Billion ≈ $3.80 Billion |
-7.59% |
| 2023-12-31 | CN¥28.09 Billion ≈ $4.11 Billion |
-6.82% |
| 2022-12-31 | CN¥30.14 Billion ≈ $4.41 Billion |
-0.51% |
| 2021-12-31 | CN¥30.30 Billion ≈ $4.43 Billion |
-6.00% |
| 2020-12-31 | CN¥32.23 Billion ≈ $4.72 Billion |
-3.26% |
| 2019-12-31 | CN¥33.32 Billion ≈ $4.88 Billion |
-1.92% |
| 2018-12-31 | CN¥33.97 Billion ≈ $4.97 Billion |
+39.25% |
| 2017-12-31 | CN¥24.39 Billion ≈ $3.57 Billion |
+126.22% |
| 2016-12-31 | CN¥10.78 Billion ≈ $1.58 Billion |
+1.55% |
| 2015-12-31 | CN¥10.62 Billion ≈ $1.55 Billion |
+35.29% |
| 2014-12-31 | CN¥7.85 Billion ≈ $1.15 Billion |
+28.02% |
| 2013-12-31 | CN¥6.13 Billion ≈ $897.19 Million |
+27.56% |
| 2012-12-31 | CN¥4.81 Billion ≈ $703.35 Million |
+24.38% |
| 2011-12-31 | CN¥3.86 Billion ≈ $565.47 Million |
+19.08% |
| 2010-12-31 | CN¥3.25 Billion ≈ $474.87 Million |
+31.27% |
| 2009-12-31 | CN¥2.47 Billion ≈ $361.76 Million |
+23.81% |
| 2008-12-31 | CN¥2.00 Billion ≈ $292.19 Million |
-9.97% |
| 2007-12-31 | CN¥2.22 Billion ≈ $324.56 Million |
-16.42% |
| 2006-12-31 | CN¥2.65 Billion ≈ $388.31 Million |
-16.58% |
| 2005-12-31 | CN¥3.18 Billion ≈ $465.46 Million |
+39.76% |
| 2004-12-31 | CN¥2.28 Billion ≈ $333.03 Million |
-11.99% |
| 2003-12-31 | CN¥2.59 Billion ≈ $378.42 Million |
+89.30% |
| 2002-12-31 | CN¥1.37 Billion ≈ $199.91 Million |
+27.81% |
| 2001-12-31 | CN¥1.07 Billion ≈ $156.41 Million |
+68.71% |
| 2000-12-31 | CN¥633.55 Million ≈ $92.71 Million |
+45.11% |
| 1999-12-31 | CN¥436.59 Million ≈ $63.89 Million |
+725.49% |
| 1998-12-31 | CN¥52.89 Million ≈ $7.74 Million |
-39.90% |
| 1997-12-31 | CN¥88.00 Million ≈ $12.88 Million |
+31.62% |
| 1996-12-31 | CN¥66.86 Million ≈ $9.78 Million |
+120.11% |
| 1995-12-31 | CN¥30.37 Million ≈ $4.44 Million |
-- |
About Shenzhen Neptunus Bioengineering Co Ltd
Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, manufacturing, and distribution of pharmaceuticals in China. The company also provides distribution of medical devices, and other medical supplies, as well as related value-added services. It serves medical institutions, drug retailers, and distributors. Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 19… Read more